Cargando...
Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis
BACKGROUND: Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunction (SND) and atrioventricular block have been previousl...
Gardado en:
| Publicado en: | BMC Neurol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185934/ https://ncbi.nlm.nih.gov/pubmed/34102997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02253-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|